arrow
A

Adrienne H. Brouwers

University Medical Centre Groningen
H指数:49
被引数:9,030

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment

程序性死亡配体1(PD-L1)PET/CT成像评估阿特珠治疗期间肿瘤饱和度

2026-09-100
OAAI
Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer

循环肿瘤细胞通过活检或FES-PET评估之外增强内分泌治疗转移性乳腺癌的预后分层

2026-04-170
OA
Smart scanning for two: [18F]FDG dose optimization for pregnant patients using LAFOV PET/CT technology

双人智能扫描:使用LAFOV PET/CT技术对孕妇进行[18F]FDG剂量优化

2026-03-170
OAAI
Author Correction: Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study

作者更正:大B细胞淋巴瘤患者治疗前及CD19定向CAR T细胞疗法期间全身CD8+ T细胞PET成像:一项2期研究

2026-02-100
OAAI
Delayed [89Zr]Zr-N-Succinyldesferal-Trastuzumab Imaging Enabled by Long-Axial-Field-of-View PET/CT

Mohr, P.; Li, Z.; van Sluis, J.; Lub-de Hooge, M.N.; van den Brom, R.R.H.; Lammertsma, A.A.; Tsoumpas, C.; Brouwers, A.H. 利用长轴向视野PET/CT实现延迟[(89)Zr]Zr-N-琥珀酰去铁胺-曲妥珠单抗显像。J. Nucl. Med. 2026, 67, 160–161. [Google Scholar] [CrossRef]

2026-01-011
PRE
Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study

大B细胞淋巴瘤患者CD8+ T细胞全身PET成像:在CD19靶向CAR T细胞治疗前后及治疗期间进行的一项2期研究

2025-11-250
OAAI
Comparative analysis of FES-PET/CT and FDG-PET/CT in patients with ER-positive metastatic invasive lobular breast cancer

FES-PET/CT与FDG-PET/CT在ER阳性转移性浸润性小叶乳腺癌患者中的比较分析

2025-09-130
PREAI
The value of 18F-FDG PET/CT and 18F-DOPA PET/CT in determining the initial surgical strategy of patients with medullary thyroid cancer: Preoperative PET/CT imaging for medullary thyroid cancer

18F-FDG PET/CT和18F-DOPA PET/CT在确定甲状腺髓样癌患者初始手术策略中的价值: 甲状腺髓样癌术前PET/CT显像

2025-03-260
OAAI
Improved Localization of Insulinomas Using 68 Ga-NODAGA-Exendin-4 PET/CT
2024-10-170
OAAI
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative,-Low, and-Positive Metastatic Breast Cancer

在HER2-Negative,低和阳性转移性乳腺癌中通过HER2 PET鉴定的全身HER2异质性

2024-09-052
PRE